Analysis of Pfizer Limited (PFIZER)
Pfizer Limited has shown a strong uptrend in the recent days, with the closing price increasing from 4379.39990 on May 21st to 4745.64990 on June 3rd. The Relative Strength Index (RSI) has been consistently above 50, indicating bullish momentum.
The Moving Average Convergence Divergence (MACD) indicator has also been positive, with the MACD line consistently above the signal line. This suggests that the bullish trend is likely to continue in the short term.
Overall, based on the RSI, MACD, and the price trend, Pfizer Limited appears to be in a strong bullish phase, and investors may consider this as a potential buying opportunity. However, it is always recommended to conduct further analysis and consider other factors before making any investment decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin: 26.306%
- Fiscal year ends: September 30, 2023
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin: 30.743%
- Most recent quarter: March 31, 2024
- Return on assets TTM: 22.073999%
- Return on equity TTM: 147.25%
Stock statistics:
- Short ratio: 1.53
- Float shares: 15,308,320,742
- Shares short: 99,287,450
- Average 10-day volume: 46,860,048
- Average 90-day volume: 57,498,254
- Shares outstanding: 15,334,099,968
- Percent held by insiders: 5.22%
- Percent held by institutions: 57.589%
- Short percent of shares outstanding: 0.65%
Valuation metrics:
- PEG ratio: 26.319502
- Forward PE: 26.319502
- Trailing PE: 29.59409
- Enterprise value: $2,950,762,332,160
- Price to book MRQ: 39.3405
- Price to sales TTM: 7.646095
- Enterprise to EBITDA: 22.763
- Enterprise to revenue: 7.732
- Market capitalization: $2,917,925,650,432
Stock price summary:
- Beta: 1.264
- 50-day moving average: $176.2646
- 200-day moving average: $181.0429
- 52-week low: $164.08
- 52-week high: $199.62
- 52-week change: 6.853%
Dividends and splits:
- Payout ratio: 14.93%
- Dividend date: May 16, 2024
- Last split date: August 31, 2020
- Ex-dividend date: May 10, 2024
- Last split factor: 4-for-1 split
- Forward annual dividend rate: $1
- 5-year average dividend yield: 0.73%
- Forward annual dividend yield: 0.5255%
- Trailing annual dividend rate: $0.97
- Trailing annual dividend yield: 0.5097%
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.
For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, representing a 2% increase from the same quarter last year. The number of analysts providing estimates is 25.
Looking ahead to the next quarter ending on September 30, 2024, the average estimate is $85,501,800,000, with a sales growth of 3% compared to the previous year. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average estimate is $357,772,000,000, showing a 1% growth from the previous year. The number of analysts providing estimates for the annual sales is 38.
In the following fiscal year ending on September 30, 2025, the average estimate is $380,772,000,000, indicating a more significant growth of 6% from the previous year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in both the short term and the long term, with a slightly more optimistic outlook for the upcoming fiscal year.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It indicates a steady but slightly slower growth trajectory for the company in the near future.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
All values are in USD. Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average above the current price. However, there is a wide range of predictions, from $164 to $275, indicating some uncertainty in the market.
Income statement 💸
These are the revenues. Here are the conclusions:
1. The company's sales have been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been increasing over the years, from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA reaching $129.2 billion in 2023.
7. Despite an increase in income tax expenses, the company has managed to grow its net income continuously.
8. The company has been effectively managing its operating expenses, with a slight increase in research and development costs over the years.
9. Non-operating interest expenses have been relatively stable, indicating a consistent financial management approach.
10. The number of basic and diluted shares outstanding has remained stable over the years.
Overall, the financial performance of the company has been positive, with consistent revenue growth, effective cost management, and increasing profitability.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been relying more on non-current assets to finance its operations over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show significant fluctuations, with large amounts being spent on common stock repurchase and debt issuance and payments.
4. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments.
5. The end cash position has been fluctuating, but overall, it has shown an increasing trend over the years.
6. Interest paid has also varied, but it seems to be relatively stable compared to other financial activities.
7. Income tax paid has fluctuated, but it generally follows the trend of the company's financial performance.
8. The company has been paying dividends consistently over the years, with varying amounts.
9. Stock-based compensation has also been a significant expense for the company.
10. Overall, the company's financial activities show a mix of stability and fluctuations, indicating a dynamic financial environment.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a growth trajectory from the EPS of $6.10 in the current year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing a trend of expected growth in both the short term and the long term.MACD of PFIZER